Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,586,623
-
Total 13F shares
-
741,213
-
Share change
-
+211,593
-
Total reported value
-
$4,500,518
-
Price per share
-
$6.08
-
Number of holders
-
11
-
Value change
-
+$1,273,959
-
Number of buys
-
6
-
Number of sells
-
2
Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q4 2020
As of 31 Dec 2020,
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
741,213 shares.
The largest 10 holders included
AIGH Capital Management LLC, VANGUARD GROUP INC, Minot Wealth Management LLC, Worth Venture Partners, LLC, BlackRock Inc., CITIGROUP INC, Tower Research Capital LLC (TRC), FEDERATED HERMES, INC., UBS Group AG, and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.